Formulation, Optimization, and Evaluation of Floating Alginate Beads for Sustained Drug Delivery

Authors

  • Uday Prakash
  • Vikas Sharma
  • Yogendra Kumar
  • Govind kirar
  • Rohit Sahu

Keywords:

Floating drug delivery, alginate beads, sustained release, entrapment efficiency, Korsmeyer-Peppas model, stability study

Abstract

This study focuses on the development and evaluation of floating alginate beads designed for sustained drug delivery. Beads were formulated using ionotropic gelation with sodium alginate, oil, and calcium chloride as key components. The impact of formulation variables on bead size, entrapment efficiency (EE), floating behavior, swelling index, and drug release was systematically investigated. Design-Expert® software was employed for optimization, and the best formulation (F3) demonstrated desirable properties including high EE, rapid floatation, sustained buoyancy, and controlled drug release. The optimized beads followed the Korsmeyer-Peppas release model, indicating non-Fickian transport, and exhibited excellent stability under ICH conditions

Downloads

Download data is not yet available.

References

Streubel A, Siepmann J, Bodmeier R. Gastroretentive drug delivery systems. Expert Opin Drug Deliv. 2006;3(2):217–233.

Talukder R, Fassihi R. Gastroretentive delivery systems: a mini-review. Drug Dev Ind Pharm. 2004;30(10):1019–1028.

Whitehead L, Fell JT, Collett JH, Sharma HL, Smith AM. Floating dosage forms: An in vivo study demonstrating prolonged gastric retention. J Control Release. 1998;55(1):3–12.

Arora S, Ali J, Ahuja A, Khar RK, Baboota S. Floating drug delivery systems: A review. AAPS PharmSciTech. 2005;6(3):E372–E390.

Singh BN, Kim KH. Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention. J Control Release. 2000;63(3):235–259.

Hari PR, Chandy T, Sharma CP. Chitosan/calcium-alginate beads for oral delivery of insulin. J ApplPolym Sci. 1996;59(11):1795–1801.

George M, Abraham TE. Polyionic hydrocolloids for the intestinal delivery of protein drugs: Alginate and chitosan—a review. J Control Release. 2006;114(1):1–14.

Pawar VK, Kansal S, Asthana S, Chourasia MK. Industrial perspective of gastroretentive drug delivery systems: Physicochemical, biopharmaceutical, technological and regulatory consideration. Expert Opin Drug Deliv. 2012;9(5):551–565.

Perumal D. Preparation and in vitro evaluation of floating microspheres containing tramadol hydrochloride. Drug Dev Ind Pharm. 2001;27(6): 501–507.

Mandal S, Nandi G, Ghosh AK. Design and optimization of alginate beads using response surface methodology for controlled delivery of cefuroxime axetil. Int J BiolMacromol. 2015;72: 1142–1152.

Pawar VK, Kansal S, Asthana S, Chourasia MK. Industrially viable and ex vivo study enabled oral delivery of insulin by encapsulating in novel pH-responsive hydrogel microparticles. Drug Dev Ind Pharm. 2013;39(9):1360–72.

Soppimath KS, Kulkarni AR, Rudzinski WE, Aminabhavi TM. Controlled release of nitric oxide from novel polyurethane urea microspheres. J Biomed Mater Res A. 2003;65(3):396–403.

Streubel A, Siepmann J, Bodmeier R. Floating matrix tablets based on low density foam powder: effects of formulation and processing parameters on drug release. Eur J Pharm Sci. 2003;18(1):37–45.

Vemula SK, Veerareddy PR. Different approaches to design and evaluation of floating drug delivery systems: a review. Int J Pharm SciNanotechnol. 2011;4(1):601–9.

El-Gibaly I. Development and in vitro evaluation of novel floating chitosan microcapsules for the nasal delivery of xylometazoline hydrochloride. Int J Pharm. 2002;233(1–2):1–14.

Sharma S, Pawar A. Low density multiparticulate system for pulsatile release of meloxicam. Int J Pharm. 2006;313(1–2):150–8.

Patil P, Joshi P, Paradkar A. Effect of formulation variables on preparation and evaluation of floating drug delivery system containing clarithromycin. Drug Dev Ind Pharm. 2007;33(3): 327–35.

Sahoo J, Murthy PN, Biswal S, Sahoo SK, Mahapatra AK. Comparative study of propranolol hydrochloride-loaded alginate and carbopol beads. AAPS PharmSciTech. 2008;9(2):577–83.

Dash S, Murthy PN, Nath L, Chowdhury P. Kinetic modeling on drug release from controlled drug delivery systems. Acta Pol Pharm. 2010;67(3):217–23.

Peppas NA. Analysis of Fickian and non-Fickian drug release from polymers. Pharm ActaHelv. 1985;60(4):110–1.

Banker GS, Anderson NR. Tablets. In: Lachman L, Lieberman HA, Kanig JL, editors. The Theory and Practice of Industrial Pharmacy. 3rd ed. Mumbai: Varghese Publishing House; 1987. p. 293–345.

Singh BN, Kim KH. Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention. J Control Release. 2000;63(3):235–59.

Costa P, Sousa Lobo JM. Modeling and comparison of dissolution profiles. Eur J Pharm Sci. 2001;13(2):123–33.

Martin A, Bustamante P, Chun AHC. Physical Pharmacy: Physical Chemical Principles in the Pharmaceutical Sciences. 4th ed. Baltimore: Lippincott Williams & Wilkins; 2002.

International Council for Harmonisation (ICH). ICH Q1A(R2) Stability Testing of New Drug Substances and Products. ICH Harmonised Tripartite Guideline; 2003.

Downloads

Published

2025-08-05

How to Cite

1.
Prakash U, Sharma V, Kumar Y, kirar G, Sahu R. Formulation, Optimization, and Evaluation of Floating Alginate Beads for Sustained Drug Delivery. J Neonatal Surg [Internet]. 2025Aug.5 [cited 2025Sep.19];14(31S):1025-32. Available from: https://www.jneonatalsurg.com/index.php/jns/article/view/8746